Mark Levin Jounce Therapeutics, Inc
As of November 16, 2021
Mark Levin Net Worth
- Net worth is estimated to be at least $1.62B
- Owns at least 1,432,638 units of Jounce Therapeutics, Inc stock
- Sold an estimated value of $37.59M in the last 4 years at Jounce Therapeutics, Inc
Mark Levin Trading
- Largest sale of shares was 1,450,000 units , worth over $17.04M on March 3, 2021
- In total has made about 10 transactions over 4 years
- Usually trades in November, with the busiest year in 2021
Third Rock Ventures III LP, Third Rock Ventures GP III LP, TRV GP III LLC, KEVIN STARR, ROBERT TEPPER, MARK LEVIN
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Mark Levin Mailing Address
- Mailing address is 29 Newbury Street 3rd Floor Boston MA 02116 MA
Jounce Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Richard Murray, Ph.D., | 2020 | $565,100 | $310,810 | $491,316 | $627,312 | $8,946 | $2,003,484 |
| Richard Murray, Ph.D., | 2019 | $540,800 | $295,500 | $275,044 | $348,665 | $8,796 | $1,468,805 |
| Hugh M. Cole | 2020 | $420,000 | $212,520 | $196,500 | $250,908 | $8,808 | $1,088,736 |
| Hugh M. Cole | 2019 | $401,700 | $153,700 | $97,900 | $124,115 | $5,709 | $783,124 |
| Kim C. Drapkin | 2020 | $398,400 | $175,300 | $174,885 | $223,308 | $8,688 | $980,581 |
| Kim C. Drapkin | 2019 | $381,200 | $145,800 | $97,900 | $124,115 | $8,796 | $757,811 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1640455/000164045521000078/jnce042621def14a.htm
Jounce Therapeutics, Inc Insider Trading
- The most recent transaction was 8,383 units sold on January 11, 2022 by Elizabeth Trehu worth over $57.7K
- In the last 5 years, insiders at Jounce Therapeutics, Inc sold an estimated value of $42.43M and bought an estimated value of $10.7M
- The most active traders are Elizabeth Trehu, Chief Medical Officer, Kimberlee C Drapkin, CFO and Treasurer, and Ca Richard Murray, CEO and President
- Insider trading is most common in June, with the busiest year in 2021
Jounce Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||